Marek David C 4
4 · Myovant Sciences Ltd. · Filed Jan 20, 2021
Insider Transaction Report
Form 4
Marek David C
DirectorPrincipal Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-01-15+306,427→ 306,427 totalExercise: $20.54Exp: 2031-01-14→ Common Stock (306,427 underlying) - Award
Common Shares
2021-01-15+223,076→ 223,076 total
Footnotes (2)
- [F1]The common shares are to be acquired upon the vesting of certain Restricted Stock Units ("RSUs") granted to the Reporting Person. The RSUs shall vest as follows: 1/4 of the common shares underlying this restricted stock unit award under the Myovant Sciences Ltd. 2020 Inducement Plan vest on January 15, 2022, and 1/16 of the common shares underlying this restricted stock unit award vest each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date.
- [F2]1/4 of the common shares underlying this option under the Myovant Sciences Ltd. 2020 Inducement Plan vest on January 15, 2022, and 1/16 of the common shares underlying this option vest each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date.